The PROCTOR trial randomized 220 post-coronary artery bypass grafting patients with saphenous vein graft (SVG) failure to native vessel percutaneous coronary intervention (PCI) (n=108) or SVG PCI (n=112). At one-year, major adverse cardiac events occurred in 34 percent with native PCI vs 19 percent with SVG PCI (HR 2.14; P=0.006).
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary Artery Bypass Graft
December 4, 2025
December 4, 2025
This meta-analysis of eight randomized clinical trials (RCT) compared no-touch (NT) vs conventional (CON) saphenous vein (SV) harvesting in coronary bypass surgery. At a 3.7-year follow-up, NT-SV harvesting showed significantly lower graft failure rates compared to CON-SV.
November 13, 2025
This international EACTS-endorsed survey assessed current practices and sought consensus on defining periprocedural myocardial infarction (PMI) after coronary artery bypass grafting (CABG).
November 6, 2025
In this article, the authors analyzed 6,693 redo coronary artery bypass grafting (CABG) operations performed between 1980 and 2020 at the Cleveland Clinic to determine whether multiarterial grafting (MAG) provides a survival benefit over single arterial grafting (SAG).
October 30, 2025
An analysis of 10 trials involving more than 10,000 patients with non-acute heart disease compared outcomes for three treatment strategies: optimal medical therapy (OMT), percutaneous coronary intervention (PCI) with OMT, and coronary artery bypass grafting (CABG) with OMT.
October 23, 2025
The authors conducted a randomized study involving 40 patients undergoing off-pump coronary artery bypass grafting (CABG) to compare techniques for preparing internal thoracic arteries.
October 16, 2025
In this article, the author reflects on 60 years of coronary artery bypass grafting (CABG), outlining its origins, the role of early surgical-cardiology collaboration, and its place alongside advances in medical therapy. Despite improvements in guideline-directed treatment, patients with extensive coronary disease still rely on CABG.
October 9, 2025
The authors conducted the NEWTON-CABG CardioLink-5 trial to assess whether intensive lowering of low-density lipoprotein cholesterol (LDL-C) lowering with evolocumab reduces saphenous vein graft (SVG) failure after coronary artery bypass grafting (CABG).
September 25, 2025
This single-center ambidirectional cohort study analyzed 617 patients with acute type A aortic dissection (ATAAD) who had coronary ostial involvement from 2019–2023.
September 11, 2025
In this multicenter retrospective study of 1,454 consecutive patients undergoing isolated coronary artery bypass grafting (CABG), the SYNTAX Score II was externally validated for predicting four-year mortality.